Jiménez, Natalia; García-de-Herreros, Marta; Reig, Óscar; Marín-Aguilera, Mercedes; Aversa, Caterina; Ferrer-Mileo, Laura; García-Esteve, Samuel; Rodríguez-Carunchio, Leonardo; Trias, Isabel; Font, Albert; Rodríguez-Vida, Alejo; Climent, Miguel-Ángel; Cros, Sara; Chirivella, Isabel; Domenech, Montserrat; Figols, Mariona; Carles, Joan; Suárez, Cristina; Herrero-Rivera, Daniel; González-Billalabeitia, Enrique; Civico, Claudia; Sala-González, Nuria; de-Porras, Vicenc-Ruiz; Ribal, María-J; Prat, Aleix; Mellado, Begoña
(ELSEVIER, 2024-08)
BACKGROUND: Androgen deprivation therapy (ADT) with docetaxel (D) and/or antiandrogen receptor therapies (ARTs) are the standard therapies in metastatic hormone-sensitive prostate cancer (mHSPC). Alterations in the tumor ...